Academic · Private company
Ludwig Institute for Cancer Research
Track this companyFree. Adds Ludwig Institute for Cancer Research to your Dealase workspace and tells you when its record changes.
Clinical trials250 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal MalignanciesPHASE1_PHASE2 · COMPLETED · started Sep 7, 2017ClinicalTrials.gov NCT02963831 · fetched Nov 12, 2026
- A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible CancersPHASE1_PHASE2 · COMPLETED · started Dec 28, 2016ClinicalTrials.gov NCT02643303 · fetched Nov 12, 2026
- Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell TransplantPHASE1 · TERMINATED · started Dec 13, 2016ClinicalTrials.gov NCT02716805 · fetched Nov 12, 2026
- Pilot Study of the Safety/Efficacy of Combination Checkpoint Blockade + External Beam Radiotherapy in Stage IV MelanomaPHASE1 · COMPLETED · started Oct 13, 2016ClinicalTrials.gov NCT02659540 · fetched Nov 12, 2026
- Phase 2 Study of Durvalumab (MEDI4736) in Patients With GlioblastomaPHASE2 · COMPLETED · started Feb 26, 2015ClinicalTrials.gov NCT02336165 · fetched Nov 12, 2026
- NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaPHASE1 · TERMINATED · started Jan 24, 2014ClinicalTrials.gov NCT01810016 · fetched Nov 12, 2026
- A Phase 1 Study to Evaluate MEDI4736 in Combination With TremelimumabPHASE1 · COMPLETED · started Dec 19, 2013ClinicalTrials.gov NCT01975831 · fetched Nov 12, 2026
- MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationPHASE1 · COMPLETED · started Sep 1, 2011ClinicalTrials.gov NCT01380145 · fetched Nov 12, 2026
- Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung CancerPHASE2 · TERMINATED · started Jan 1, 2011ClinicalTrials.gov NCT01266018 · fetched Nov 12, 2026
- Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancersPHASE1 · COMPLETED · started Nov 14, 2008ClinicalTrials.gov NCT00803569 · fetched Nov 12, 2026
- Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic MelanomaPHASE2 · COMPLETED · started Mar 28, 2008ClinicalTrials.gov NCT00679289 · fetched Nov 12, 2026
- Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerPHASE1 · COMPLETED · started Mar 1, 2008ClinicalTrials.gov NCT00616941 · fetched Nov 12, 2026
- Study of ADI-PEG 20 in Patients With Advanced MelanomaPHASE1_PHASE2 · COMPLETED · started Jul 1, 2007ClinicalTrials.gov NCT00520299 · fetched Nov 12, 2026
- NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)PHASE1 · COMPLETED · started Aug 24, 2005ClinicalTrials.gov NCT00142454 · fetched Nov 12, 2026
- Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250PHASE1 · COMPLETED · started Jul 6, 2005ClinicalTrials.gov NCT00199875 · fetched Nov 12, 2026
- A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial SarcomaPHASE2 · TERMINATED · started Jun 8, 2005ClinicalTrials.gov NCT00140855 · fetched Nov 12, 2026
- Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal CancerPHASE2 · COMPLETED · started Dec 1, 2004ClinicalTrials.gov NCT00112957 · fetched Nov 12, 2026
- NY-ESO-1 Plasmid DNA (pPJV7611) Cancer VaccinePHASE1 · COMPLETED · started Sep 27, 2004ClinicalTrials.gov NCT00199849 · fetched Nov 12, 2026
- Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)PHASE1 · COMPLETED · started Jul 26, 2004ClinicalTrials.gov NCT00084799 · fetched Nov 12, 2026
- Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial CancerPHASE1 · COMPLETED · started Nov 1, 2003ClinicalTrials.gov NCT00072410 · fetched Nov 12, 2026
- Vaccine Therapy in Treating Patients With Transitional Cell CarcinomasPHASE1 · COMPLETED · started Oct 28, 2003ClinicalTrials.gov NCT00070070 · fetched Nov 12, 2026
- Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerPHASE1 · COMPLETED · started Jun 23, 2003ClinicalTrials.gov NCT00066729 · fetched Nov 12, 2026
- Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian CancerPHASE1 · TERMINATED · started Aug 2, 2000ClinicalTrials.gov NCT00006099 · fetched Nov 12, 2026
- Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal CancerPHASE1 · TERMINATED · started Jul 12, 2000ClinicalTrials.gov NCT00006046 · fetched Nov 12, 2026
- Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney CancerPHASE1_PHASE2 · COMPLETED · started Nov 17, 1998ClinicalTrials.gov NCT00003102 · fetched Nov 12, 2026